Nevada Cannabis Board Investigates Dispensaries For Tainted Products

The Nevada Cannabis Compliance Board has launched an inspection of three Las Vegas-based dispensaries alleged to have sold contaminated flower.

The flower failed laboratory testing for yeast and mold, coliforms, as well as Enterobacteriaceae and Aspergillus. The Department of Taxation and CCB banned the sale of Cherry OG F3 in March.

Despite the CCB’s instruction to destroy or return the cannabis to the cultivator, stores continued to sell the product during May, CCB said.

The board opted to investigate the following businesses accused of selling nearly 375 grams of tainted product between May 19 and June 29:

•             Waveseer of Las Vegas (Jenny’s Dispensary)

•             Paradise Wellness Center (Las Vegas ReLeaf)

•             Desert Aire Wellness (Sahara Wellness)

There have been no illnesses reported by customers, according to the CCB.

In addition, customers are called on to check any Cherry OG products for the source package #1A404030000076F000006649.

Meanwhile, 4Front Ventures Corp. FFNT FFNTF recently managed to smooth out all legacy regulatory issues concerning its Georgetown, Massachusetts-based Mission facility.

The Phoenix, Arizona-based cannabis facility operator came to an understanding with the Massachusetts Cannabis Control Commission by agreeing to pay a $350,000 fine.

The regulatory body accused 4Front’s Healthy Pharms, which was rebranded as Mission, for the use of unpermitted pesticides during the cannabis cultivation process.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewscannabis industrycannabis sales
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.


Loading...